Clinical trial Recruiting at 1 site Interventional Ages 18 and up

PRP injections versus hyaluronic acid for advanced knee osteoarthritis

Official title: Efficacy of Therapy With Intra-articular Injections of PRP Compared With Therapy With Intra-articular Injections of HA, in Patients With Grade III or IV GONArthrosis: a Prospective Randomized Open-label Study

Run by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT07016672 · Data updated 2026-11-12

This project will test whether platelet-rich plasma (PRP) injections or hyaluronic acid (HA) injections better reduce pain and improve function for people with moderate-to-severe knee osteoarthritis.

More Knee Osteoarthritis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorCentre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Academic / other
Locations1 site (Toulon, Var)
StatusRecruiting
StartedSeptember 18, 2025
Main results expectedDecember 2027
Study endsOctober 2028
Registry record updatedJuly 7, 2026
Trial IDNCT07016672 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (≥18 years) with MRI-confirmed unilateral grade III or IV knee osteoarthritis, pain ≥3/10, BMI <35, able to give informed consent, and covered by social security.

Probably not a fit

Patients with early-stage OA, recent intra-articular PRP/HA/corticosteroid injections, uncontrolled medical conditions (including recent cancer), pregnancy or breastfeeding, anticoagulation that cannot be paused, or those under legal guardianship may not be eligible or likely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will run a randomized, open-label study comparing intra-articular PRP injections to hyaluronic acid (HA) injections in patients with MRI-confirmed grade III-IV knee osteoarthritis at Hôpital Sainte Musse in Toulon. Participants will be followed for 12 months after their last injection and outcomes will include pain (VAS), function (WOMAC), and quality of life (EQ-5D-5L). The trial uses standard-of-care injection procedures and validated questionnaires to measure changes over time. The aim is to determine which injection better reduces the functional impact of advanced gonarthrosis.

Why it matters

Potential benefit: If successful, the better-performing injection could reduce pain, improve daily function, and potentially delay the need for knee replacement surgery.

How similar studies have gone: Previous trials comparing PRP and HA have shown mixed results, with some reporting PRP offers greater short- to mid-term improvements in pain and function but evidence is inconsistent and less clear for advanced (grade III-IV) disease.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years ;
2. MRI confirmed grade III or IV unilateral gonarthrosis ;
3. Pain ≥ 3/10 on the visual analogue scale (VAS);
4. Patient with a BMI \< 35
5. Patient capable of giving consent prior to participation in the study;
6. Affiliated or entitled under a social security scheme.

Exclusion Criteria:

1. Non-steroidal anti-inflammatory drugs\* or corticosteroids\*\* taken in the 7 days prior to inclusion;
2. Local injection of hyaluronic acid in the 2 months prior to inclusion;
3. Local injection of PRP within 1 year prior to inclusion;
4. Local injection of corticosteroids within 5 months prior to inclusion;
5. Current anticoagulant treatment that cannot be stopped during the hyaluronic acid or PRP injection protocol period;
6. Patient diagnosed with any type of cancer in the last 3 years;
7. Pregnant women, women in labour or breast-feeding women;
8. Patients under judicial protection (guardianship, curatorship, etc.) or safeguard of justice;
9. Any other reason which, in the opinion of the investigator, could interfere with the evaluation of the study objectives.

   * Acetylsalicylic acid is allowed when it is prescribed as an antiplatelet agent at doses lower than or equal to 160 mg per day. It has, indeed, no anti-inflammatory effect at these doses.

     * Corticosteroids can be administered when they have a local action different from the one applied to the treated knee (cutaneous, instiled or inhaled routes).

Where it's running

  • Centre Hospitalier Intercommunal de Toulon- La Seyne sur Mer - Hôpital Sainte Musse
    Toulon, Var, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.